The healthcare world is seeing a major shift in diabetes management with the emergence of GLP-1 transdermal devices. These systems offer a seemingly more convenient alternative to shots of GLP-1 drugs, lessening the need for daily needle pokes. The approach administers the medication directly through the surface, arguably enhancing person adherence